-
Track & Monitor
NewInnovation in pharma: phenotypic drug screening
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the pharma industry’s phenotypic drug screening segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge.
-
Sector Analysis
NewOsteoporosis in Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2033
This report covers the 7MM (US, France, Germany, Italy, Spain, UK, Japan) and provides an Excel-based forecast model for the Osteoporosis market through 2033. Osteoporosis is defined as a systemic skeletal disease characterized by low bone mass and micro-architectural deterioration of bone tissue, predisposing a person to bone fragility and susceptibility to fracture. Common sites of fracture include the spine, hip, distal forearm, and proximal humerus. Such fractures are a major cause of morbidity in the general population and a patient’s...
-
Sector Analysis
NewChronic Kidney Disease in Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2033
This report covers the 7MM (US, France, Germany, Italy, Spain, UK, Japan) and provides an Excel-based forecast model for the Chronic Kidney Disease (CKD) market through 2033. GlobalData estimates the sales of CKD therapeutics to be approximately $2.2 billion across the 7MM in 2023. By 2033, GlobalData expects the CKD market to grow at a strong compound annual growth rate (CAGR) of 19.6%, reaching sales of $13.5 billion by the end of the forecast period. The major drivers of CKD...
-
Sector Analysis
NewNiemann Pick Type C Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2031
The prevalence of Niemann Pick Type C (NPC) is increasing at a steady rate, in line with population growth in the 3MM at an AGR of 0.29%. Currently, the treatment regimen for NPC in the 3MM is entirely limited to the use of miglustat (Yargesa, Zavesca or generic). There are several unmet needs in this space, including therapies with low or minimal toxicity and novel therapies with improved efficacy. The NPC late-stage R&D pipeline is focused on developing medicines with...
-
Sector Analysis
NewChronic Kidney Disease Epidemiology Analysis and Forecast to 2033
Chronic kidney disease (CKD), or chronic renal disease (International Classification of Diseases 10th Revision [ICD-10] code = N18), is a condition characterized by a gradual loss of kidney function over time. This leads to the accumulation of excess fluid and waste in the body. In the early stages, CKD is a largely asymptomatic condition. As the disease progresses, symptoms worsen and eventually lead to kidney failure (Centers for Disease Control and Prevention, 2024a). Advanced chronic kidney disease can lead to...
-
Product Insights
NewPoly [ADP Ribose] Polymerase 2 – Drugs In Development, 2024
The Poly [ADP Ribose] Polymerase 2 pipeline drugs market research report outlays comprehensive information on the Poly [ADP Ribose] Polymerase 2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Infectious Disease, and Undisclosed which include indications of Ovarian Cancer, Solid Tumor, Coronavirus Disease 2019 (COVID-19), Coronavirus Disease 2019 (COVID-19) Pneumonia, and Unspecified. It also reviews key...
-
Product Insights
NewSolute Carrier Family 22 Member 12 – Drugs In Development, 2024
The Solute Carrier Family 22 Member 12 pipeline drugs market research report outlays comprehensive information on the Solute Carrier Family 22 Member 12 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Musculoskeletal Disorders, Metabolic Disorders, Genito Urinary System, and Gastrointestinal which include indications of Gouty Arthritis (Gout), Hyperuricemia, Chronic Kidney Disease (Chronic Renal Failure), Metabolic Dysfunction-Associated Steatohepatitis...
-
Product Insights
NewE3 Ubiquitin Protein Ligase Mdm2 – Drugs In Development, 2024
The E3 Ubiquitin Protein Ligase Mdm2 pipeline drugs market research report outlays comprehensive information on the E3 Ubiquitin Protein Ligase Mdm2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, and Ophthalmology which include indications of Solid Tumor, Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia), and Proliferative Vitreoretinopathy (PVR). It also reviews key players involved in E3...
-
Product Insights
NewTGF Beta Receptor Type 1 – Drugs In Development, 2024
The TGF Beta Receptor Type 1 pipeline drugs market research report outlays comprehensive information on the TGF Beta Receptor Type 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Respiratory, Dermatology, and Gastrointestinal which include indications of Solid Tumor, Esophageal Cancer, Idiopathic Pulmonary Fibrosis, Pulmonary Fibrosis, Wounds, Keloids, Crohn's Disease (Regional Enteritis), and Oral Mucositis. It...
-
Product Insights
New5-Hydroxytryptamine Receptor 3 – Drugs In Development, 2024
The 5-Hydroxytryptamine Receptor 3 pipeline drugs market research report outlays comprehensive information on the 5-Hydroxytryptamine Receptor 3 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Gastrointestinal, Toxicology, Central Nervous System, and Immunology which include indications of Post Operative Nausea And Vomiting, Irritable Bowel Syndrome, Chemotherapy Induced Nausea and Vomiting, Radiation Induced Nausea and Vomiting (RINV), Parkinson's Disease,...